Trial Profile
A Double Blind (3rd Party Open), Randomised, Placebo-Controlled, Dose Escalation Study To Investigate The Safety, Toleration, And Pharmacokinetics Of Multiple Oral Doses Of PF-03893787 In Healthy Subjects.
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 19 Dec 2009
Price :
$35
*
At a glance
- Drugs Adriforant (Primary)
- Indications Asthma
- Focus Adverse reactions
- 20 Oct 2009 New trial record